Grunwald J E
Invest Ophthalmol Vis Sci. 1986 Dec;27(12):1713-9.
The effect of topical timolol maleate 0.5% on the retinal circulation was investigated in 14 normal subjects using laser Doppler velocimetry and monochromatic fundus photography. In a double masked, randomized design, one eye received two drops of timolol maleate 0.5% and the fellow eye received two drops of placebo. Vessel diameter, maximum velocity of red blood cells, and volumetric blood flow rate were determined in a major temporal vein of each eye just prior to the instillation of drops, and then 90 min later. In comparison to the baseline value, there was a significantly larger average percentage increase in maximum velocity of red blood cells and volumetric blood flow rate in the timolol-treated eyes (11.0% and 13.2%, respectively) than in the control eyes (2.2% and 1.5%, respectively, paired t-test, P less than 0.05). No significant change in venous diameter was detected. No significant linear correlations were found between the percentage change in maximum velocity of red blood cells and mean brachial artery blood pressure, and between the percentage change in volumetric blood flow rate and mean brachial artery pressure in the placebo-treated eyes, whereas significant correlations were present between these quantities in the timolol-treated eyes (P less than 0.01 and P less than 0.05, respectively). The lack of such correlations in the control eyes is probably due to autoregulation of the retinal circulation. The presence of correlations in the timolol-treated eyes suggests that the drug may affect the capacity of the retina to autoregulate.
采用激光多普勒测速法和单色眼底摄影术,对14名正常受试者局部应用0.5%马来酸噻吗洛尔对视网膜循环的影响进行了研究。在双盲、随机设计中,一只眼睛滴入两滴0.5%马来酸噻吗洛尔,另一只眼睛滴入两滴安慰剂。在滴入药物前及90分钟后,分别测定每只眼睛一条主要颞静脉的血管直径、红细胞最大速度和容积血流率。与基线值相比,马来酸噻吗洛尔治疗组眼睛的红细胞最大速度和容积血流率的平均百分比增加值(分别为11.0%和13.2%)显著大于对照组眼睛(分别为2.2%和1.5%,配对t检验,P<0.05)。未检测到静脉直径有显著变化。在安慰剂治疗组眼睛中,红细胞最大速度百分比变化与平均肱动脉血压之间以及容积血流率百分比变化与平均肱动脉血压之间未发现显著线性相关性,而在马来酸噻吗洛尔治疗组眼睛中这些量之间存在显著相关性(分别为P<0.01和P<0.05)。对照组眼睛中缺乏这种相关性可能是由于视网膜循环的自身调节。马来酸噻吗洛尔治疗组眼睛中存在相关性表明该药物可能影响视网膜自身调节的能力。